
Maczone XP 500mg/62.5mg Injection
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Maczone XP 500mg/62.5mg Injection
Combiflox 500 mg/62.5 mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and preventing infection spread. Administration must be strictly under medical guidance. Consistent adherence to the prescribed regimen is crucial; premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Prior to commencing treatment, disclose all current medications to your physician. Consult your doctor if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing to driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your physician may order blood tests and other diagnostics to monitor treatment response.
Uses of Maczone XP 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Maczone XP 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Maczone XP 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Maczone XP 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Maczone XP 500mg/62.5mg Injection works:
Ceftriaxone/Tazobactum injection (Maczone XP 500 mg/62.5 mg) combines a cephalosporin antibiotic, Ceftriaxone, with a beta-lactamase inhibitor, Tazobactum. Ceftriaxone disrupts bacterial cell wall synthesis, hindering bacterial growth. Tazobactum counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Maczone XP 500 mg/62.5 mg Injection consumption alongside alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Maczone XP 500 mg/62.5 mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Maczone XP 500 mg/62.5 mg Injection to breastfeeding mothers requires careful consideration. It's recommended to discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Maczone XP 500 mg/62.5 mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Maczone XP 500 mg/62.5 mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Maczone XP 500 mg/62.5 mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Maczone XP 500 mg/62.5 mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Maczone XP 500mg/62.5mg Injection :
Omit a Maczone XP 500 mg/62.5 mg Injection dose? Seek medical advice immediately.
Facts to Know About Maczone XP 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
